Combinatorial Immunotherapy with Agonistic CD40 Activates Dendritic Cells to Express IL12 and Overcomes PD-1 Resistance — YUMMER1.7 (YR) tumor (8 days post-tumor initiation, either untreated or 24 hours post-treatment), scRNA-seq